Clinical Trials Sponsored by Biocine

Total 182 results

Biokine Therapeutics Ltd

Completed

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Multiple Myeloma

Israel
Biosite

Completed

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Heart Failure

United States
Biosite

Withdrawn

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) (CLEAR)

Cardiovascular Disease

United States
Biosite

Withdrawn

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Acute Coronary Syndrome

United States
Biosite

Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-02)

Oral Anticoagulation

United States
Biosite

Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome (Midas 3)

Acute Coronary Syndrome

United States
Biocinese

Unknown

Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg

Nutritional and Metabolic Diseases

Brazil
Biocinese

Unknown

Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Brazil
Biocinese

Unknown

Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State (BET04cap)

Hyperplasia Prostatic

Brazil
Biosite

Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

Acute Kidney Injury

Italy
Biosite

Completed

Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy (ENCINO)

Cardiovascular Surgery With Coronary Angiography

United States
Biosite

Completed

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury (EVOLVE)

Kidney Failure, Acute

United States, Canada
Biosite

Completed

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU (REAL-ICU)

Acute Kidney Injury

United States, Canada
Biosite

Completed

SHORTness of Breath In the Emergency Department (SHORTIE)

Heart Failure | Pulmonary Embolism | Acute Myocardial Infarction

United States
Biosite

Withdrawn

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department (ESTIMATE)

Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
Biosite

Completed

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-01)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
Biosite

Completed

Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain

Myocardial Infarction | Acute Coronary Syndrome

Germany
Biosite

Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Stroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

United States, Canada, Germany, Switzerland, United Kingdom
Biosite

Withdrawn

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) (MINDSET)

Sepsis

United States
Biosite

Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Heart Failure

United States
Biosite

Completed

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin) (ECLIPSE 03)

Coagulation

United States
Biosite

Completed

Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF (GALLANT)

Acute Decompensated Heart Failure

United States, Netherlands, Switzerland
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
Lipocine Inc.

Completed

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH)

United States
Nobel Biocare

Completed

Study Assessing the Safety and Effectiveness of the Nobel Biocare N1 Concept System. (Evolution)

Dental Implant

Hungary, Italy, Netherlands
Lipocine Inc.

Completed

Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men

Hypogonadism, Male

United States
Nobel Biocare

Completed

A 5 Year Clinical Study on NobelActive 3 mm Implants (NA 3 MM)

Single Tooth Implant
Lipocine Inc.

Completed

Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) (DF)

Hypogonadism, Male
Nobel Biocare

Completed

A Study of Dental Implants Coated With Bone Morphogenetic Protein

Alveolar Ridge Abnormality

United States
Nobel Biocare

Terminated

All-On-4® Treatment Concept

Edentulous

Germany
BioFire Diagnostics, LLC
BioFire Defense LLC

Completed

Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel

Evaluation of Test Panel

United States
Bionime Corporation

Not yet recruiting

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

Diabetes Mellitus

United States
BioLite, Inc.

Not yet recruiting

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Triple Negative Breast Cancer
Lipocine Inc.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Liver Cirrhosis | Sarcopenia

United States
Nobel Biocare

Completed

The TREFOIL Concept 5 Year Clinical Investigation

Edentulous or Failing Dentition Mandible

Italy, United States, Australia, Chile, Spain
Lipocine Inc.

Active, not recruiting

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

NASH - Nonalcoholic Steatohepatitis

United States
BioLite, Inc.

Completed

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Major Depressive Disorder

Taiwan, United States
Nobel Biocare

Completed

A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants

Healthy | Implant
Nobel Biocare

Completed

A 1-year Clinical Investigation on the On1 Concept (T-190)

Implant

Belgium, Italy, Lithuania, Netherlands
Nobel Biocare

Unknown

A 1-year Clinical Investigation on the the CREOS™ XENOGAIN Bone Graft SUBSTITUTE

Horizontal Bone Augmentation

Germany, Italy, Serbia
Nobel Biocare

Terminated

NobelProceraTM Bridge Shaded Zirconia

Posterior Bridge Restoration

Germany
Nobel Biocare

Completed

Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use

Partial Edentulism | Complete Edentulism
Bionime Corporation

Not yet recruiting

Effectiveness and Safety of the RIGHTEST™ Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

Diabetes Mellitus
Nobel Biocare

Recruiting

A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components

Marginal Bone Level Change

Denmark
BioLite, Inc.

Not yet recruiting

A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Myelodysplastic Syndrome (MDS)
BioLite, Inc.

Completed

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Nobel Biocare

Terminated

Nobel Procera Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD

Partial Edentulism

Germany
BioLite, Inc.

Completed

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

Major Depressive Disorder

Taiwan
Lipocine Inc.

Completed

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). (DV)

Hypogonadism, Male
Nobel Biocare

Terminated

A 5 Year Clinical Investigation on Creos Xenoprotect (CXP)

Implant

Germany

3

Subscribe